NeuroHarmonics
PrivateLast Round
Seed
Jan 22, 2026
Total Funding Raised
$2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroHarmonics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in January 2026.
NeuroHarmonics is a deeptech company developing a non-invasive neurotechnology platform that uses ultrasound-based brain modulation to treat neurological and psychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroHarmonics Comparables
Compare NeuroHarmonics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPIRE Therapeutics, Inc. | 89% | |
| Grey Matter Neurosciences | 87% | |
| Attune Neurosciences | 84% |
For institutional investors. Book with your work email.
NeuroHarmonics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NeuroHarmonics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Seed |
| EPSRC | Grant |
| Speedinvest | Seed |
| Jumpspace Ventures | Seed |
| Albion Capital | Seed |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
$2M raised from Albion Capital and Fusion Fund.
- Sep 4, 2025
Grew 67% QoQ from 6 to 10 employees.
For institutional investors. Book with your work email.
NeuroHarmonics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroHarmonics's valuation, stock price, and market status.
Is NeuroHarmonics a public or private company?
NeuroHarmonics is a private company.
What is the current stock price of NeuroHarmonics?
NeuroHarmonics is a private company, so its shares have no public market price. Caplight tracks NeuroHarmonics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroHarmonics worth (valuation)?
Valuation information for NeuroHarmonics is not publicly available.
Can I buy NeuroHarmonics stock?
NeuroHarmonics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroHarmonics's last funding round?
NeuroHarmonics's most recent funding round was Seed on January 22, 2026.
Who are the main investors in NeuroHarmonics?
Key investors in NeuroHarmonics include Fusion Fund, EPSRC, Speedinvest, Jumpspace Ventures, Albion Capital.
Will NeuroHarmonics IPO soon?
No public IPO plans have been announced for NeuroHarmonics.
How can I track NeuroHarmonics secondary market activity?
Caplight tracks bids, offers, and trades in NeuroHarmonics's shares on secondary markets.